The tumor uptake of the 89Zr-labeled anti-HER3 affibody, ZHER3:8698, increased under AUY922 treatment and correlated with the HER3 upregulation in MCF-7 xenografts [81]. The gene discussed is ERBB3; the disease is neoplasm.